HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Philosophy To Defend Time in a Bottle Claims With NARB Appeal

This article was originally published in The Rose Sheet

Executive Summary

NAD recommends discontinuation of numerous claims, many on product packaging, for the Coty brand’s Time in a Bottle Age-Defying Serum, citing flaws in the advertiser’s six-month, blinded clinical study. Philosophy will appeal to the National Advertising Review Board, arguing that “left uncorrected, the NAD’s decision would … disincentivize manufacturers from conducting similar comprehensive studies.”

You may also be interested in...



NARB Panel Finds Philosophy's Study Reliable For Time In A Bottle Claims

The National Advertising Review Board's ruling on Coty/Philosophy's claims promoting the Time in a Bottle serum is considerably more favorable than the National Advertising Division's initial decision last year. Notably, the appellate body finds the advertiser's key clinical study reliable to support modified versions of statements NAD said should be discontinued, including a "two years younger" anti-aging claim.

U.K. Advertising Authority OKs Palmer’s Stretch Mark, Dove Soap Spots

Challengers refer claims for Palmer’s Skin Therapy Oil and Unilever’s Dove soap offerings to the Advertising Standards Authority, the latter brand’s TV advertising undergoing review in the United Kingdom for the second time in one year.

Are Beauty Ads Held To Unique Standards? NARB Ruling Spurs Debate

At the National Advertising Division’s Annual Conference, NAD staffers, FTC officials and attorneys discussed whether beauty ads are regulated differently from advertising in other industries. L’Oreal’s successful appeal of a recent NAD decision regarding the use of lash inserts in Maybelline mascara ads could set a new and questionable precedent, according to NAD Director Andrea Levine.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019253

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel